Literature DB >> 15370942

Differences in peripheral noradrenergic function among actively drinking and abstinent alcohol-dependent individuals.

Ashwin A Patkar1, Charles A Marsden, Prakash C Naik, David A Kendall, Raman Gopalakrishnan, Michael J Vergare, Stephen P Weinstein.   

Abstract

We examined whether excessive alcohol consumption was related to changes in plasma levels of noradrenaline (NA) and whether these changes recover following abstinence. We also explored whether there were differences in NA levels between Type I and Type II alcoholics and controls during active drinking and abstinence. Plasma concentrations of NA were determined in (1) 27 Caucasian men with alcohol dependence who were regularly drinking (active drinkers) within 24 hours of hospitalization, (2) 29 Caucasian alcohol-dependent men who were in remission (abstinent for a minimum of three months), and (3) 28 race- and gender-matched healthy controls. NA concentrations were significantly higher in actively drinking alcohol-dependent subjects compared to those in remission and controls. While Type I and Type II alcoholic individuals differed across clinical measures, NA levels were similar in the two subtypes. Both subtypes showed an elevation in NA levels during active drinking compared to controls, but NA levels did not differ between the two subtypes and controls during remission. The findings indicate that chronic exposure to alcohol may lead to disturbances in NA activity that may manifest in early abstinence. However, the changes in NA activity appears to normalize after a longer period of abstinence. Alterations in NA activity do not seem to be specific for Type I or Type II subtypes of alcoholism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370942     DOI: 10.1080/10550490490459898

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  10 in total

1.  Adolescent social isolation increases anxiety-like behavior and ethanol intake and impairs fear extinction in adulthood: Possible role of disrupted noradrenergic signaling.

Authors:  M J Skelly; A E Chappell; E Carter; J L Weiner
Journal:  Neuropharmacology       Date:  2015-06-01       Impact factor: 5.250

2.  Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial.

Authors:  George A Kenna; Carolina L Haass-Koffler; William H Zywiak; Steven M Edwards; Michael B Brickley; Robert M Swift; Lorenzo Leggio
Journal:  Addict Biol       Date:  2015-06-02       Impact factor: 4.280

3.  Prazosin Prevents Increased Anxiety Behavior That Occurs in Response to Stress During Alcohol Deprivations.

Authors:  Dennis D Rasmussen; Carrie L Kincaid; Janice C Froehlich
Journal:  Alcohol Alcohol       Date:  2016-10-26       Impact factor: 2.826

4.  Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings.

Authors:  Helen C Fox; George M Anderson; Keri Tuit; Julie Hansen; Anne Kimmerling; Kristen M Siedlarz; Peter T Morgan; Rajita Sinha
Journal:  Alcohol Clin Exp Res       Date:  2011-09-15       Impact factor: 3.455

Review 5.  Adolescent Social Isolation as a Model of Heightened Vulnerability to Comorbid Alcoholism and Anxiety Disorders.

Authors:  Tracy R Butler; Anushree N Karkhanis; Sara R Jones; Jeffrey L Weiner
Journal:  Alcohol Clin Exp Res       Date:  2016-05-07       Impact factor: 3.455

Review 6.  The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.

Authors:  Helen Fox; Rajita Sinha
Journal:  Adv Pharmacol       Date:  2014

7.  β1-adrenoceptor activation is required for ethanol enhancement of lateral paracapsular GABAergic synapses in the rat basolateral amygdala.

Authors:  Yuval Silberman; Olusegun J Ariwodola; Jeff L Weiner
Journal:  J Pharmacol Exp Ther       Date:  2012-08-17       Impact factor: 4.030

8.  COMT genotype influences the effect of alcohol on blood pressure: results from the COMBINE study.

Authors:  Scott H Stewart; Gabor Oroszi; Patrick K Randall; Raymond F Anton
Journal:  Am J Hypertens       Date:  2008-11-20       Impact factor: 2.689

Review 9.  Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption.

Authors:  Howard C Becker
Journal:  Alcohol Res       Date:  2012

10.  Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use.

Authors:  Mary J Skelly; Jeff L Weiner
Journal:  Brain Behav       Date:  2014-04-14       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.